Carnitine and its use in reducing cardiac toxicity

Details Carnitine and its use in reducing cardiac toxicity Carnitine and its use in reducing cardiac toxicity

1977-05-23

1981-05-12

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Magnetic imaging agent

424180, 424181, 424319, 424 2, A61K 4900, A61K 3170, A61K 3171, A61K 31195

Patent

active

042671639

ABSTRACT:
Carnitine may be administered for the purpose of reducing cardiac toxicity resulting from administration of a cytostat.

REFERENCES:
patent: 2278123 (1942-03-01), Heyn
patent: 2761807 (1956-09-01), Borsook et al.

Affiliated with

Also associated with

Rating

Carnitine and its use in reducing cardiac toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carnitine and its use in reducing cardiac toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carnitine and its use in reducing cardiac toxicity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2046408